Discovery of Potent and Selective Diaminopyrimidine-Based EGFR T790M Resistance Mutation inhibitors

来源 :2016年长三角药物化学研讨会 | 被引量 : 0次 | 上传用户:forde88
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
A small molecules library with structure diversity was constructed through diversity-oriented synthesis (DOS) strategy.1 Seven novel scaffolds were quickly synthesized through transition metal catalyz
会议
Sphingomyelin synthase is a proposed potential therapeutic target for atherosclerosis1,obesity and insulin resistance2.Sphingomyelin(SM) is the most abundant sphingolipids in the cell,with ubiquitous
会议
Cancer metastasis is the major cause of cancer-associated death[1].The molecular mechanism is complex,involving the change of multi-step,multi-stage and multi-gene.Based on biological testing of tumor
The FDA approval of the peptide-based proteasome inhibitors bortezomib,carfilzomib,and ixazomib in 2003,2012,and 2015,respectively,has validated the proteasome as an important target in the treatment
With aim to overcome the instability and poor membrane permeability of EGCG,1 a series of prodrugs of EGCG and its derivatives (Pro-EGCGs) were designed,synthesized,and biological evaluation for their
会议
会议
会议
会议